Biology Goes Open Source

Looks like the big guys are catchin' on:

Biology Goes Open Source

Some of the world's biggest drug companies are finding that their genetic research is worth more to them if they give it away.

Novartis (nyse: NVS - news - people ), the Basel, Switzerland, drug giant, has helped uncover which of the 20,000 genes identified by the Human Genome Project are likely to be associated with diabetes. But rather than hoard this information, as drug firms have traditionally done, it is making it available for free on the World Wide Web.

Read the article at Forbes.com>>